Tuesday, June 15, 2021
10:00am
Opening Remarks
Tony Kingsley
President & CEO
10:10am
Unmet Medical Needs in SMA
Jill Jarecki, Ph.D.
Chief Scientific Officer, Cure SMA
10:20am
Apitegromab TOPAZ Phase 2 Data and Phase 3 Trial Design Considerations
Yung Chyung, M.D.
Chief Medical Officer
10:45am
Panel Discussion on Apitegromab’s Therapeutic Potential in SMA
Thomas Crawford, M.D. and Basil Darras, M.D.
Moderated by Yung Chyung, M.D.